Status:

UNKNOWN

Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy

Lead Sponsor:

Shanghai Pulmonary Hospital, Shanghai, China

Conditions:

Thymoma

Myasthenia Gravis Associated With Thymoma

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Recently, robotic-assisted thoracic surgery (RATS) has become into as an alternative approach to either, open surgery or video-assisted thoracoscopic surgery. The superiorities of RATS have been repor...

Detailed Description

The gold standard technique for thymectomy used to be transsternal approach. Advancements in modern technology bring many evolutions in minimally invasive surgery such as Video-assisted thoracic surge...

Eligibility Criteria

Inclusion

  • Patients with Myasthenia Gravis and(or) thymoma need to perform thymectomy.
  • Agree to accept Robotic Assisted Thoracic Surgery and have signed informed consent.

Exclusion

  • Cardiopulmonary function cannot tolerate thoracoscopic surgery or exist other contraindication.
  • Thymic carcinoma.
  • Thoracic deformity.

Key Trial Info

Start Date :

May 10 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05262582

Start Date

May 10 2022

End Date

January 1 2025

Last Update

May 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Pulmonary Hospital

Shanghai, Shanghai Municipality, China, 200433